Mortality benefits of influenza vaccination in elderly people

The Lancet Infectious Diseases

Volumn 8, Issue 8, 2008, Pages 460-461

  Thijs, Carel ^a   Beyer, Walter EP ^b   Govaert, Phile ME ^a   Sprenger, Marc JW ^c   Dinant, Geert Jan ^a   Knottnerus, André ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

ANTIBODY TITER; CLINICAL TRIAL; DRUG EFFICACY; ELDERLY CARE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LETTER; NETHERLANDS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 47349105854     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(08)70161-0     Document Type: Letter

References (3)

1. Simonsen L., Taylor R., Viboud C., Miller M., and Jackson L. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 (2007) 658-666
2. Govaert T., Thijs C., Masurel N., Sprenger M., Dinant G., and Knottnerus J. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
3. Govaert T., Sprenger M., Dinant G., Aretz K., Masurel N., and Knottnerus J. Immune response to influenza vaccination in elderly people. A randomized double-blind placebo-controlled trial. Vaccine 12 (1994) 1185-1189